Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1206217C details a green synthesis of aziridines using ionic liquids, offering high cis-selectivity and catalyst reusability for cost-effective pharmaceutical intermediate manufacturing.
Patent CN107118143A reveals nickel-catalyzed synthesis offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN117105817B details safe synthesis avoiding toxic cyanide. Reliable supplier for pharmaceutical intermediates ensuring cost reduction and supply continuity.
Novel synthesis route for 5-fluoro-4-imino-3-alkyl-1-arylsulfonyl-3,4-dihydropyrimidin-2(1H)-one offering cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN110563696B reveals a robust method for heteroatom-containing cyclohexene halides, offering significant cost reduction and simplified purification for fine chemical manufacturing.
Novel catalytic route for high-purity fluoroquinolone intermediates. Reduces alkali usage and boosts yield to 82.5% via one-pot synthesis.
Patent CN100408555C reveals a high-yield synthesis of 4-chloro-3-hydroxybutyronitrile using basic catalysts, offering significant cost reduction and waste minimization for supply chains.
Patent CN112374976B details a 3-step route to (1E,4E)-1,5-bis(2-methoxyphenyl)pent-1,4-dien-3-one avoiding heavy metals and column chromatography for cost-effective manufacturing.
Patent CN107899611B details bifunctional catalysts combining cinchona alkaloids and porphyrins for visible-light driven asymmetric synthesis, offering greener pharmaceutical intermediate production.
Patent CN115850252A discloses a novel iron-iodine co-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN108129373B details a novel 3-step palladium-catalyzed route for diaryl pyrroles, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel copper-catalyzed route for 5,6-dihydrobenzo[c]acridine offers high atom economy and mild conditions for scalable pharmaceutical manufacturing.
Novel continuous synthesis method for high-purity 3-methyl-3-butene-1-alcohol. Reduces pressure and temperature while enhancing supply chain reliability for global buyers.
Patent CN108707109A details a safer synthesis route for pyroxsulam intermediates. Eliminating cryogenic conditions reduces costs and enhances supply chain reliability for agrochemical manufacturing.
Patent CN113004326B discloses advanced bidentate phosphine ligands enhancing adipaldehyde selectivity up to 60%, offering a viable route for nylon precursors.
Patent CN107793325A reveals a green boric acid catalyzed route for synthetic capsaicin, offering high purity and reduced environmental impact for supply chains.
Novel patent CN110878104B details a safer two-step route for chiral 1,2-bis(2,5-diphenylphosphino)ethane, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN113105502B reveals a safer, high-yield route for tert-butyldiphenylphosphine using tert-butanol, offering significant cost reduction and supply chain stability for pharma intermediates.
Patent CN101033212A enables high purity DMAP via one-pot bromination. Reduces waste and ensures supply chain stability for pharmaceutical intermediates.
Patent CN113735752A reveals a novel metal-free route for S-aryl isothiourea synthesis, offering significant cost reduction and simplified supply chains for API manufacturing.